CHF Solutions is a medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow® and the Aquadex SmartFlow™ systems. The Aquadex SmartFlow™ system is indicated for temporary (up to eight hours) or extended (longer than eight hours in patients who require hospitalization) use in adult and pediatric patients weighing 20kg or more whose fluid overload is unresponsive to medical management, including diuretics. We show 17 historical shares outstanding datapoints in our CHFS shares outstanding history coverage, used to compute CHFS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CHFS market cap history over the course of time is important for investors
interested in comparing CHFS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CHFS versus a peer is one thing; comparing
CHFS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CHFS can fluctuate over the course of history.
With this page we aim to empower investors researching CHFS by allowing them to research the CHFS market cap history. |
Free CHFS Email Alerts:
Video: The Importance of Market Cap
